NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

市場調查報告書

數位治療市場:按應用,產品類型和銷售渠道:全球機會分析和行業預測(2020-2027)

Digital Therapeutics Market by Application, Product Type, and Sales Channel : Global Opportunity Analysis and Industry Forecast, 2020-2027

出版商 Allied Market Research 商品編碼 972133
出版日期 內容資訊 英文 280 Pages
商品交期: 2-3個工作天內
價格
數位治療市場:按應用,產品類型和銷售渠道:全球機會分析和行業預測(2020-2027) Digital Therapeutics Market by Application, Product Type, and Sales Channel : Global Opportunity Analysis and Industry Forecast, 2020-2027
出版日期: 2020年09月30日內容資訊: 英文 280 Pages
簡介

2019年全球數位治療市場為28.8億美元。預計在預測期內,該市場的複合年增長率為20.5%,到2027年將達到138億美元。

數位治療為患者提供了基於證據的治療干預。用於預防,管理或治療醫療狀況的軟件程序和設備有助於實現這一點。數位治療軟件應用程序可以單獨使用,也可以與設備,藥物或其他治療方法結合使用,以提供患者護理和保健效果。這些產品融合了先進的技術,設計,易用性,臨床驗證和數據安全最佳實踐。這些產品在使用前已經過監管機構的審查和批准。此外,數字治療為患者,醫療保健專業人員和付款人提供了智能且可訪問的工具,可通過高質量,安全,有效的面向數據的干預措施來解決各種症狀。

越來越多的智能手機和平板電腦帶有醫療保健應用程序,管理醫療保健成本的需求增加,以及慢性病的發病率上升,正在推動全球數位治療市場的增長。但是,發展中國家對數位治療的意識不足以及患者數據隱私問題阻礙了市場的增長。預計驅動因素的影響將超過限制因素的影響。因此,從2020年到2027年,市場預計將以20.5%的複合年增長率增長。相反,新興市場有望在未來為市場參與者提供巨大的增長機會。

該報告調查了全球數位治療市場,並概述了市場以及按應用程序,產品類型,銷售渠道,地區和進入市場的公司概況的趨勢。

目錄

第1章簡介

第2章執行摘要

第3章市場概述

  • 市場定義和範圍
  • 主要發現
    • 主要投資口袋
    • 主要成功策略
  • 2019年最佳球員排名
  • 波特的五力分析
  • 市場動態
    • 促進因素
      • 通過醫療保健應用程序越來越多地採用智能手機和平板電腦
      • 越來越需要管理醫療保健費用
      • 慢性病發病率增加
    • 抑制因素
      • 發展中國家對數位治療的認識不足
      • 患者數據隱私問題
    • 市場機會
      • 新興市場提供巨大的增長機會
  • 分析COVID-19對數位治療市場的影響
  • 政府法規對全球數位治療市場的影響
    • 美國FDA上市前批准和批准要求
    • 歐盟的上市前通關和批准要求
    • 日本上市前通關和批准要求
  • 採用的策略:前10名創業者
    • Meru Health, Inc.
    • Bold Health Limited
    • BehaVR、LLC
    • Naluri Hidup Sdn Bhd
    • Big Health
    • Hinge Health, Inc.
    • Glooko, Inc.
    • Holmusk Pte. Ltd.
    • Wellthy Therapeutics Pvt Ltd.
    • Virta Health Corp.
  • 用於數位治療的主要數字技術
    • 移動健康(m健康)
    • 個性化醫療
    • 數位認知行為療法(CBT)
    • 可穿戴設備和傳感器
  • 數位藥物開發所需的人力資源
  • 使用通過數位治療獲得的患者數據
    • 收集的個人信息類型:公司的DTx

第4章數位治療市場:按應用

  • 概述
    • 市場規模和預測
  • 糖尿病
    • 主要市場趨勢和增長機會
    • 市場規模和預測
    • 市場分析:按國家
  • 肥胖
    • 主要市場趨勢和增長機會
    • 市場規模和預測
    • 市場分析:按國家
  • 心血管疾病
    • 主要市場趨勢和增長機會
    • 市場規模和預測
    • 市場分析:按國家
  • 中樞神經系統(CNS)疾病
    • 主要市場趨勢和增長機會
    • 市場規模和預測
    • 市場分析:按國家
  • 胃腸道疾病
    • 主要市場趨勢和增長機會
    • 市場規模和預測
    • 市場分析:按國家
  • 呼吸系統疾病
    • 主要市場趨勢和增長機會
    • 市場規模和預測
    • 市場分析:按國家
  • 禁止吸煙
    • 主要市場趨勢和增長機會
    • 市場規模和預測
    • 市場分析:按國家
  • 其他
    • 主要市場趨勢和增長機會
    • 市場規模和預測
    • 市場分析:按國家

第5章數位治療市場:按產品

  • 概述
    • 市場規模和預測
  • 軟件
    • 市場規模和預測
    • 市場分析:按國家
  • 設備
    • 市場規模和預測
    • 市場分析:按國家

第6章數位治療市場:按銷售渠道

  • 概述
    • 市場規模和預測
  • 公司之間(B2B)
    • 市場規模和預測:按類型
      • 僱主
      • 醫療保健提供者
      • 其他
    • 市場規模和預測:按地區
    • 市場分析:按國家
  • 商業與消費者
    • 市場規模和預測:按類型
      • 病人
      • 保姆
    • 市場規模和預測:按地區
    • 市場分析:按國家

第7章數位治療市場:按地區

  • 概述
    • 市場規模和預測
  • 北美
    • 主要市場趨勢,增長因素和機遇
    • 北美數位藥品市場:按國家
      • 美國數位治療藥物市場:按應用
      • 美國數位藥品市場:按產品類型
      • 美國數位藥品市場:按銷售渠道劃分
      • 加拿大數位治療市場:按用途
      • 加拿大數位治療市場:按產品類型
      • 加拿大數位治療市場:按銷售渠道劃分
      • 墨西哥數位藥品市場:按應用
      • 墨西哥數位藥品市場:按產品類型劃分
      • 墨西哥數位藥品市場:按銷售渠道劃分
    • 北美數位治療市場:按應用
    • 北美數位治療市場:按產品類型
    • 北美數位治療藥物市場:按銷售渠道劃分
  • 歐洲
    • 主要市場趨勢,增長因素和機遇
    • 歐洲數位藥品市場:按國家
      • 英國數位藥品市場:按應用
      • 英國數位治療市場:按產品類型
      • 英國數位治療市場:按銷售渠道劃分
      • 德國數位藥品市場:按應用
      • 德國數位藥品市場:按產品類型劃分
      • 德國數位藥品市場:按銷售渠道劃分
      • 法國數位藥品市場:按應用
      • 法國數位藥品市場:按產品類型劃分
      • 法國數位藥品市場:按銷售渠道劃分
      • 意大利數位治療藥物市場:按應用
      • 意大利數位藥品市場:按產品類型劃分
      • 意大利數位藥品市場:按銷售渠道劃分
      • 西班牙數位藥品市場:按應用
      • 西班牙數位藥品市場:按產品類型劃分
      • 西班牙數位藥品市場:按銷售渠道劃分
      • 其他歐洲數位治療藥物市場:按應用
      • 其他歐洲數位治療藥物市場:按產品類型
      • 其他歐洲數位治療藥物市場:按銷售渠道劃分
    • 歐洲數位治療市場:按應用
    • 歐洲數位藥品市場:按產品類型劃分
    • 歐洲數位藥品市場:按銷售渠道劃分
  • 亞太地區
    • 主要市場趨勢,增長因素和機遇
    • 亞太數位藥品市場:按國家
      • 日本數位治療藥物市場:按應用
      • 日本數位治療藥物市場:按產品類型
      • 日本數位治療藥物市場:按銷售渠道劃分
      • 中國數位治療藥物市場:按應用
      • 中國數位治療藥物市場:按產品類型劃分
      • 中國數位治療藥物市場:按銷售渠道劃分
      • 澳大利亞數位治療市場:按用途
      • 澳大利亞數位治療市場:按產品類型
      • 澳大利亞數位藥品市場:按銷售渠道劃分
      • 印度數位治療藥物市場:按應用
      • 印度數位藥品市場:按產品類型劃分
      • 印度數位藥品市場:按銷售渠道劃分
      • 韓國數位治療藥物市場:按應用
      • 韓國數位治療藥物市場:按產品類型
      • 韓國數位治療藥物市場:按銷售渠道劃分
      • 其他亞太數位治療藥物市場:按應用
      • 其他亞太數位藥品市場:按產品類型
      • 其他亞太數位治療藥物市場:按銷售渠道劃分
    • 亞太數位治療藥物市場:按應用
    • 亞太數位治療市場:按產品類型
    • 亞太數位治療藥物市場:按銷售渠道劃分
  • 拉美
    • 主要市場趨勢,增長因素和機遇
    • LAMEA數位治療藥物市場:按國家
      • 巴西數位藥品市場:按應用
      • 巴西數位藥品市場:按產品類型劃分
      • 巴西數位藥品市場:按銷售渠道劃分
      • 土耳其數位藥品市場:按應用
      • 土耳其數位藥品市場:按產品類型劃分
      • 土耳其數位藥品市場:按銷售渠道劃分
      • 沙特阿拉伯的數位治療市場:按用途
      • 沙特阿拉伯數位治療市場:按產品類型
      • 沙特阿拉伯數位治療市場:按銷售渠道劃分
      • 南非數位藥品市場:按應用
      • 南非數位藥品市場:按產品類型劃分
      • 南非數位藥品市場:按銷售渠道劃分
      • LAMEA數位治療市場的其餘部分:按應用
      • LAMEA數位治療市場的其餘部分:按產品類型
      • LAMEA數位治療市場的其餘部分:按銷售渠道劃分
    • LAMEA數位治療藥物市場:按應用
    • LAMEA數位治療藥物市場:按產品類型
    • LAMEA數位治療藥物市場:按銷售渠道劃分

第8章公司簡介

  • 2MORROW, INC.
  • AKILI INTERACTIVE LABS, INC.
  • CLICK THERAPEUTICS, INC.
  • FITBIT, INC. (TWINE HEALTH, INC.)
  • HAPPIFY, INC.
  • KAIA HEALTH
  • LIVONGO HEALTH, INC.
  • MEDTRONIC PLC.
  • OMADA HEALTH, INC.
  • PEAR THERAPEUTICS, INC.
  • PROTEUS DIGITAL HEALTH, INC.
  • RESMED, INC. (PROPELLER HEALTH)
  • VOLUNTIS, INC.
  • WELLDOC, INC.
目錄
Product Code: A01787

Title:
Digital Therapeutics Market by Application (Diabetes, Obesity, Cardiovascular Disease (CVD), Central Nervous System (CNS) Disease, Respiratory Disease, Smoking Cessation, Gastrointestinal Disorder (GID), and Others), Product Type (Software and Device), and Sales Channel (Business-to-Business (B2B), Business-to-Consumer (B2C)): Global Opportunity Analysis and Industry Forecast, 2020-2027.

The global digital therapeutics market was valued at $2.88 billion in 2019, and is expected to reach $13.80 billion by 2027 with a CAGR of 20.5% during the forecast period.

Digital therapeutics provides evidence-based therapeutic interventions to patients. It is driven by software programs and devices to prevent, manage, or treat a medical condition. Digital therapeutics software application can be used independently or in combination with devices, medications, or any other therapies to provide patient care and health outcomes. These products incorporate advanced technology, best practices regarding design, usability, clinical validation, and data security. These products are reviewed and approved by regulatory bodies before use. Furthermore, digital therapeutics empower patients, healthcare providers, and payers with intelligent and accessible tools for addressing a wide range of conditions through high quality, safe, and effective data-driven interventions.

Increase in adoption of smartphones and tablets, coupled with healthcare apps, growth in need to control healthcare cost, and rise in incidences of chronic diseases drive growth of the global digital therapeutics market. However, lack of awareness regarding digital therapeutics in developing countries and patient data privacy concerns restrain the market growth. The impact of the driving factors is expected to surpass that of the restraints. Hence, the market is projected to grow at a CAGR of 20.5% from 2020 to 2027. On the contrary, emerging markets are anticipated to offer significant growth opportunities for the market players in the future.

The global digital therapeutics market is segmented into application, product type, sales channel, and region. By application, it is divided into diabetes, obesity, cardio vascular diseases (CVD), central nervous system (CNS) disease, respiratory diseases, smoking cessation, gastrointestinal disorders, and others. By product type, it is classified into software and devices. Further, on the basis of sales channel, it is bifurcated into business-to-business (B2B) and business-to-consumers (B2C). Furthermore, business-to-business (B2B) is categorized into employers, healthcare providers, and others. By business-to-consumers, it is classified into patients and caregivers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

This report provides a detailed quantitative analysis of the current market trends and future estimations from 2020 to 2027, which assists to identify the prevailing market opportunities.

An in-depth analysis of various regions is anticipated to provide a detailed understanding of the current trends to enable stakeholders to formulate region-specific plans.

A comprehensive analysis of the factors that drive and restrain the growth of the global digital therapeutics market is provided.

An extensive analysis of various regions provides insights that allow companies to strategically plan their business moves.

KEY MARKET SEGMENTS

By Application

Diabetes

Obesity

Cardiovascular Disease (CVD)

Central Nervous System (CNS) Disease

Respiratory Disease

Smoking Cessation

Gastrointestinal Disorder (GID)

Others

By Product Type

Software

Device

By Sales Channel

Business-to-Business (B2B)

Employer

Healthcare Provider

Others

Business-to-Consumer (B2C)

Patient

Caregiver

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

France

UK

Italy

Spain

Rest of Europe

Asia-Pacific

Australia

Japan

India

China

South Korea

Rest of Asia-Pacific

LAMEA

Brazil

Turkey

Saudi Arabia

South Africa

Rest of LAMEA

KEY MARKET PLAYERS

2MORROW, Inc.

Akili Interactive Labs, Inc.

Click Therapeutics, Inc.

Fitbit, Inc. (Twine Health, Inc.)

Happify, Inc.

Kaia Health

Livongo Health, Inc.

Medtronic Plc.

Omada Health, Inc.

Pear Therapeutics, Inc.

Proteus Digital Health, Inc.

Resmed, Inc. (Propeller Health)

Voluntis, Inc.

Welldoc, Inc.

The other players in the value chain include (profiles not included in the report):

  • Canary Health Inc.
  • Mango Health Inc.
  • Noom, Inc.
  • Dthera Sciences

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

  • 1.1.Report description
  • 1.2.Key benefits for stakeholders
  • 1.3.Key Market Segments
  • 1.4.Research methodology
    • 1.4.1.Secondary research
    • 1.4.2.Primary research
    • 1.4.3.Analyst tools & models

CHAPTER 2:EXECUTIVE SUMMARY

  • 2.1.CXO perspective

CHAPTER 3:MARKET OVERVIEW

  • 3.1.Market definition and scope
  • 3.2.Key findings
    • 3.2.1.Top investment pockets
    • 3.2.2.Top winning strategies
  • 3.3.Top player positioning, 2019
  • 3.4.Porter's five forces analysis
  • 3.5.Market dynamics
    • 3.5.1.Drivers
      • 3.5.1.1.Increase in adoption of smartphones and tablets, coupled with healthcare apps
      • 3.5.1.2.Growth in need to control healthcare costs
      • 3.5.1.3.Rise in incidences of chronic diseases
    • 3.5.2.Restraints
      • 3.5.2.1.Lack of awareness regarding digital therapeutics in developing countries
      • 3.5.2.2.Patient data privacy concerns
    • 3.5.3.Opportunity
      • 3.5.3.1.Emerging markets offer significant growth opportunities
  • 3.6.Impact analysis of COVID-19 on the digital therapeutics market
  • 3.7.Impact of government regulations on global digital therapeutics market
    • 3.7.1.U.S. FDA's premarket clearance and approval requirements
    • 3.7.2.European Union premarket clearance and approval requirements
    • 3.7.3.Japan premarket clearance and approval requirements
  • 3.8.Strategy adopted by top 10 start-ups
    • 3.8.1.Meru Health, Inc.
    • 3.8.2.Bold Health Limited
    • 3.8.3.BehaVR, LLC
    • 3.8.4.Naluri Hidup Sdn Bhd
    • 3.8.5.Big Health
    • 3.8.6.Hinge Health, Inc.
    • 3.8.7.Glooko, Inc.
    • 3.8.8.Holmusk Pte. Ltd.
    • 3.8.9.Wellthy Therapeutics Pvt Ltd.
    • 3.8.10.Virta Health Corp.
  • 3.9.Key digital technologies for digital therapeutics
    • 3.9.1.Mobile health (mHealth)
    • 3.9.2.Personalized healthcare
    • 3.9.3.Digital Cognitive Behavior Therapy (CBT)
    • 3.9.4.Wearable devices and sensors
  • 3.10.Necessary human resources required for digital therapeutics development
  • 3.11.Usage of patient data acquired from digital therapeutics
    • 3.11.1.Types of personal information that are collected by DTx companies

CHAPTER 4:DIGITAL THERAPEUTICS MARKET, BY APPLICATION

  • 4.1.Overview
    • 4.1.1.Market size and forecast
  • 4.2.Diabetes
    • 4.2.1.Key market trends and growth opportunities
    • 4.2.2.Market size and forecast
    • 4.2.3.Market analysis, by country
  • 4.3.Obesity
    • 4.3.1.Key market trends and growth opportunities
    • 4.3.2.Market size and forecast
    • 4.3.3.Market analysis, by country
  • 4.4.Cardiovascular diseases
    • 4.4.1.Key market trends and growth opportunities
    • 4.4.2.Market size and forecast
    • 4.4.3.Market analysis, by country
  • 4.5.Central nervous system (CNS) diseases
    • 4.5.1.Key market trends and growth opportunities
    • 4.5.2.Market size and forecast
    • 4.5.3.Market analysis, by country
  • 4.6.Gastrointestinal disorder
    • 4.6.1.Key market trends and growth opportunities
    • 4.6.2.Market size and forecast
    • 4.6.3.Market analysis, by country
  • 4.7.Respiratory diseases
    • 4.7.1.Key market trends and growth opportunities
    • 4.7.2.Market size and forecast
    • 4.7.3.Market analysis, by country
  • 4.8.Smoking cessation
    • 4.8.1.Key market trends and growth opportunities
    • 4.8.2.Market size and forecast
    • 4.8.3.Market analysis, by country
  • 4.9.Others
    • 4.9.1.Key market trends and growth opportunities
    • 4.9.2.Market size and forecast
    • 4.9.3.Market analysis, by country

CHAPTER 5:DIGITAL THERAPEUTICS MARKET, BY PRODUCT

  • 5.1.Overview
    • 5.1.1.Market size and forecast
  • 5.2.Software
    • 5.2.1.Market size and forecast
    • 5.2.2.Market analysis, by country
  • 5.3.Devices
    • 5.3.1.Market size and forecast
    • 5.3.2.Market analysis, by country

CHAPTER 6:DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL

  • 6.1.Overview
    • 6.1.1.Market size and forecast
  • 6.2.Business-to-business (B2B)
    • 6.2.1.Market size and forecast, by type
      • 6.2.1.1.Employer
      • 6.2.1.1.1.Market size and forecast
      • 6.2.1.2.Healthcare Providers
      • 6.2.1.2.1.Market size and forecast
      • 6.2.1.3.Others
      • 6.2.1.3.1.Market size and forecast
    • 6.2.2.Market size and forecast, by region
    • 6.2.3.Market analysis, by country
  • 6.3.Business-to-consumers
    • 6.3.1.Market size and forecast, by type
      • 6.3.1.1.Patients
      • 6.3.1.1.1.Market size and forecast
      • 6.3.1.2.Caregivers
      • 6.3.1.2.1.Market size and forecast
    • 6.3.2.Market size and forecast, by region
    • 6.3.3.Market analysis, by country

CHAPTER 7:DIGITAL THERAPEUTICS MARKET, BY REGION

  • 7.1.Overview
    • 7.1.1.Market size and forecast
  • 7.2.North America
    • 7.2.1.Key market trends, growth factors, and opportunities
    • 7.2.2.North America digital therapeutics market, by country
      • 7.2.2.1.U.S. digital therapeutics market, by application
      • 7.2.2.2.U.S digital therapeutics market, by product type
      • 7.2.2.3.U.S. digital therapeutics market, by sales channel
      • 7.2.2.4.Canada digital therapeutics market, by application
      • 7.2.2.5.Canada digital therapeutics market, by product type
      • 7.2.2.6.Canada digital therapeutics market, by sales channel
      • 7.2.2.7.Mexico digital therapeutics market, by application
      • 7.2.2.8.Mexico digital therapeutics market, by product type
      • 7.2.2.9.Mexico digital therapeutics market, by sales channel
    • 7.2.3.North America digital therapeutics market, by application
    • 7.2.4.North America digital therapeutics market, by product type
    • 7.2.5.North America digital therapeutics market, by sales channel
  • 7.3.Europe
    • 7.3.1.Key market trends, growth factors, and opportunities
    • 7.3.2.Europe digital therapeutics market, by country
      • 7.3.2.1.UK digital therapeutics market, by application
      • 7.3.2.2.UK digital therapeutics market, by product type
      • 7.3.2.3.UK digital therapeutics market, by sales channel
      • 7.3.2.4.Germany digital therapeutics market, by application
      • 7.3.2.5.Germany digital therapeutics market, by product type
      • 7.3.2.6.Germany digital therapeutics market, by sales channel
      • 7.3.2.7.France digital therapeutics market, by application
      • 7.3.2.8.France digital therapeutics market, by product type
      • 7.3.2.9.France digital therapeutics market, by sales channel
      • 7.3.2.10.Italy digital therapeutics market, by application
      • 7.3.2.11.Italy digital therapeutics market, by product type
      • 7.3.2.12.Italy digital therapeutics market, by sales channel
      • 7.3.2.13.Spain digital therapeutics market, by application
      • 7.3.2.14.Spain digital therapeutics market, by product type
      • 7.3.2.15.Spain digital therapeutics market, by sales channel
      • 7.3.2.16.Rest of Europe digital therapeutics market, by application
      • 7.3.2.17.Rest of Europe digital therapeutics market, by product type
      • 7.3.2.18.Rest of Europe digital therapeutics market, by sales channel
    • 7.3.3.Europe digital therapeutics market, by application
    • 7.3.4.Europe digital therapeutics market, by product type
    • 7.3.5.Europe digital therapeutics market, by sales channel
  • 7.4.Asia-pacific
    • 7.4.1.Key market trends, growth factors, and opportunities
    • 7.4.2.Asia-Pacific digital therapeutics market, by country
      • 7.4.2.1.Japan digital therapeutics market, by application
      • 7.4.2.2.Japan digital therapeutics market, by product type
      • 7.4.2.3.Japan digital therapeutics market, by sales channel
      • 7.4.2.4.China digital therapeutics market, by application
      • 7.4.2.5.China digital therapeutics market, by product type
      • 7.4.2.6.China digital therapeutics market, by sales channel
      • 7.4.2.7.Australia digital therapeutics market, by application
      • 7.4.2.8.Australia digital therapeutics market, by product type
      • 7.4.2.9.Australia digital therapeutics market, by sales channel
      • 7.4.2.10.India digital therapeutics market, by application
      • 7.4.2.11.India digital therapeutics market, by product type
      • 7.4.2.12.India digital therapeutics market, by sales channel
      • 7.4.2.13.South Korea digital therapeutics market, by application
      • 7.4.2.14.South Korea digital therapeutics market, by product type
      • 7.4.2.15.South Korea digital therapeutics market, by sales channel
      • 7.4.2.16.Rest of Asia-Pacific digital therapeutics market, by application
      • 7.4.2.17.Rest of Asia-Pacific digital therapeutics market, by product type
      • 7.4.2.18.Rest of Asia-Pacific digital therapeutics market, by sales channel
    • 7.4.3.Asia-Pacific digital therapeutics market, by application
    • 7.4.4.Asia-Pacific digital therapeutics market, by product type
    • 7.4.5.Asia-Pacific digital therapeutics market, by sales channel
  • 7.5.LAMEA
    • 7.5.1.Key market trends, growth factors, and opportunities
    • 7.5.2.LAMEA digital therapeutics market, by country
      • 7.5.2.1.Brazil digital therapeutics market, by application
      • 7.5.2.2.Brazil digital therapeutics market, by product type
      • 7.5.2.3.Brazil digital therapeutics market, by sales channel
      • 7.5.2.4.Turkey digital therapeutics market, by application
      • 7.5.2.5.Turkey digital therapeutics market, by product type
      • 7.5.2.6.Turkey digital therapeutics market, by sales channel
      • 7.5.2.7.Saudi Arabia digital therapeutics market, by application
      • 7.5.2.8.Saudi Arabia digital therapeutics market, by product type
      • 7.5.2.9.Saudi Arabia digital therapeutics market, by sales channel
      • 7.5.2.10.South Africa digital therapeutics market, by application
      • 7.5.2.11.South Africa digital therapeutics market, by product type
      • 7.5.2.12.South Africa digital therapeutics market, by sales channel
      • 7.5.2.13.Rest of LAMEA digital therapeutics market, by application
      • 7.5.2.14.Rest of LAMEA digital therapeutics market, by product type
      • 7.5.2.15.Rest of LAMEA digital therapeutics market, by sales channel
    • 7.5.3.LAMEA digital therapeutics market, by application
    • 7.5.4.LAMEA digital therapeutics market, by product type
    • 7.5.5.LAMEA digital therapeutics market, by sales channel

CHAPTER 8:COMPANY PROFILES

  • 8.1.2MORROW, INC.
    • 8.1.1.Company overview
    • 8.1.2.Company snapshot
    • 8.1.3.Operating business segments
    • 8.1.4.Product portfolio
    • 8.1.5.Key strategic moves and developments
  • 8.2.AKILI INTERACTIVE LABS, INC.
    • 8.2.1.Company overview
    • 8.2.2.Company snapshot
    • 8.2.3.Product portfolio
    • 8.2.4.Key strategic moves and developments
  • 8.3.CLICK THERAPEUTICS, INC.
    • 8.3.1.Company overview
    • 8.3.2.Company snapshot
    • 8.3.3.Operating business segments
    • 8.3.4.Product portfolio
    • 8.3.5.Key strategic moves and developments
  • 8.4.FITBIT, INC. (TWINE HEALTH, INC.)
    • 8.4.1.Company overview
    • 8.4.2.Company snapshot
    • 8.4.3.Product portfolio
    • 8.4.4.Business performance
    • 8.4.5.Key strategic moves and developments
  • 8.5.HAPPIFY, INC.
    • 8.5.1.Company overview
    • 8.5.2.Company snapshot
    • 8.5.3.Product portfolio
    • 8.5.4.Key strategic moves and developments
  • 8.6.KAIA HEALTH
    • 8.6.1.Company overview
    • 8.6.2.Company snapshot
    • 8.6.3.Product portfolio
    • 8.6.4.Key strategic moves and developments
  • 8.7.LIVONGO HEALTH, INC.
    • 8.7.1.Company overview
    • 8.7.2.Company snapshot
    • 8.7.3.Product portfolio
    • 8.7.4.Key strategic moves and developments
  • 8.8.MEDTRONIC PLC.
    • 8.8.1.Company overview
    • 8.8.2.Company snapshot
    • 8.8.3.Operating business segments
    • 8.8.4.Product portfolio
    • 8.8.5.Business performance
    • 8.8.6.Key strategic moves and developments
  • 8.9.OMADA HEALTH, INC.
    • 8.9.1.Company overview
    • 8.9.2.Company snapshot
    • 8.9.3.Operating business segments
    • 8.9.4.Product portfolio
    • 8.9.5.Key strategic moves and developments
  • 8.10.PEAR THERAPEUTICS, INC.
    • 8.10.1.Company overview
    • 8.10.2.Company snapshot
    • 8.10.3.Product portfolio
    • 8.10.4.Key strategic moves and developments
  • 8.11.PROTEUS DIGITAL HEALTH, INC.
    • 8.11.1.Company overview
    • 8.11.2.Company snapshot
    • 8.11.3.Operating business segments
    • 8.11.4.Product portfolio
    • 8.11.5.Key strategic moves and developments
  • 8.12.RESMED, INC. (PROPELLER HEALTH)
    • 8.12.1.Company overview
    • 8.12.2.Company snapshot
    • 8.12.3.Operating business segments
    • 8.12.4.Product portfolio
    • 8.12.5.Business performance
    • 8.12.6.Key strategic moves and developments
  • 8.13.VOLUNTIS, INC.
    • 8.13.1.Company overview
    • 8.13.2.Company snapshot
    • 8.13.3.Operating business segments
    • 8.13.4.Product portfolio
    • 8.13.5.Business performance
    • 8.13.6.Key strategic moves and developments
  • 8.14.WELLDOC, INC.
    • 8.14.1.Company overview
    • 8.14.2.Company snapshot
    • 8.14.3.Operating business segments
    • 8.14.4.Product portfolio
    • 8.14.5.Key strategic moves and developments

LIST OF TABLES

  • TABLE 01.FDA CLASSIFICATION OF MEDICAL DEVICES
  • TABLE 02.DIGITAL SKILLS REQUIRED FOR EMPLOYEES DEDICATED FOR DTX DEVELOPMENTS
  • TABLE 03.RANGE OF NUMBER OF EMPLOYEES WITH DIGITAL SKILLS DEDICATED FOR DIGITAL THERAPEUTICS DEVELOPMENTS, BY COMPANY
  • TABLE 04.GLOBAL DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 05.DIGITAL THERAPEUTICS MARKET FOR DIABETES, BY REGION, 2019-2027 ($MILLION)
  • TABLE 06.DIGITAL THERAPEUTICS MARKET FOR OBESITY, BY REGION, 2019-2027 ($MILLION)
  • TABLE 07.DIGITAL THERAPEUTICS MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2019-2027 ($MILLION)
  • TABLE 08.DIGITAL THERAPEUTICS MARKET FOR CENTRAL NERVOUS SYSTEM DISEASES, BY REGION, 2019-2027 ($MILLION)
  • TABLE 09.SMART PILLS FOR CAPSULE ENDOSCOPY, DRUG DELIVERY, AND PATIENT MONITORING AVAILABLE IN THE MARKET
  • TABLE 10.DIGITAL THERAPEUTICS MARKET FOR GASTROINTESTINAL DISORDER, BY REGION, 2019-2027 ($MILLION)
  • TABLE 11.DIGITAL THERAPEUTICS MARKET FOR RESPIRATORY DISEASES, BY REGION, 2019-2027 ($MILLION)
  • TABLE 12.DIGITAL THERAPEUTICS MARKET FOR SMOKING CESSATION, BY REGION, 2019-2027 ($MILLION)
  • TABLE 13.DIGITAL THERAPEUTICS MARKET FOR OTHERS, BY REGION, 2019-2027 ($MILLION)
  • TABLE 14.GLOBAL DIGITAL THERAPEUTICS MARKET, BY PRODUCT, 2019-2027 ($MILLION)
  • TABLE 15.DIGITAL THERAPEUTIC APPLICATIONS AND SOFTWARE PLATFORMS
  • TABLE 16.GLOBAL DIGITAL THERAPEUTICS MARKET FOR SOFTWARE, BY REGION, 2019-2027 ($MILLION)
  • TABLE 17.GLOBAL DIGITAL THERAPEUTICS MARKET FOR DEVICES, BY REGION, 2019-2027 ($MILLION)
  • TABLE 18.GLOBAL DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019-2027 ($MILLION)
  • TABLE 19.DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 20.DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY REGION, 2019-2027 ($MILLION)
  • TABLE 21.DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY TYPE, 2019-2027 ($MILLION)
  • TABLE 22.DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY REGION, 2019-2027 ($MILLION)
  • TABLE 23.DIGITAL THERAPEUTICS MARKET REVENUE, BY REGION, 2019-2027 ($MILLION)
  • TABLE 24.NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 25.U.S. DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 26.U.S. DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
  • TABLE 27.U.S. DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019-2027 ($MILLION)
  • TABLE 28.CANADA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 29.CANADA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
  • TABLE 30.CANADA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019-2027 ($MILLION)
  • TABLE 31.MEXICO DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 32.MEXICO DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
  • TABLE 33.MEXICO DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019-2027 ($MILLION)
  • TABLE 34.NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 35.NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
  • TABLE 36.NORTH AMERICA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019-2027 ($MILLION)
  • TABLE 37.EUROPE DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 38.UK DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 39.UK DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
  • TABLE 40.UK DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019-2027 ($MILLION)
  • TABLE 41.GERMANY DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 42.GERMANY DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
  • TABLE 43.GERMANY DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019-2027 ($MILLION)
  • TABLE 44.FRANCE DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 45.FRANCE DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
  • TABLE 46.FRANCE DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019-2027 ($MILLION)
  • TABLE 47.ITALY DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 48.ITALY DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
  • TABLE 49.ITALY DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019-2027 ($MILLION)
  • TABLE 50.SPAIN DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 51.SPAIN DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
  • TABLE 52.SPAIN DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019-2027 ($MILLION)
  • TABLE 53.REST OF EUROPE DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 54.REST OF EUROPE DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
  • TABLE 55.REST OF EUROPE DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019-2027 ($MILLION)
  • TABLE 56.EUROPE DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 57.EUROPE DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
  • TABLE 58.EUROPE DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019-2027 ($MILLION)
  • TABLE 59.ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 60.JAPAN DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 61.JAPAN DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
  • TABLE 62.JAPAN DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019-2027 ($MILLION)
  • TABLE 63.CHINA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 64.CHINA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
  • TABLE 65.CHINA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019-2027 ($MILLION)
  • TABLE 66.AUSTRALIA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 67.AUSTRALIA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
  • TABLE 68.AUSTRALIA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019-2027 ($MILLION)
  • TABLE 69.INDIA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 70.INDIA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
  • TABLE 71.INDIA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019-2027 ($MILLION)
  • TABLE 72.SOUTH KOREA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 73.SOUTH KOREA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
  • TABLE 74.SOUTH KOREA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019-2027 ($MILLION)
  • TABLE 75.REST OF ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 76.REST OF ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
  • TABLE 77.REST OF ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019-2027 ($MILLION)
  • TABLE 78.ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 79.ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
  • TABLE 80.ASIA-PACIFIC DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019-2027 ($MILLION)
  • TABLE 81.LAMEA DIGITAL THERAPEUTICS MARKET, BY COUNTRY, 2019-2027 ($MILLION)
  • TABLE 82.BRAZIL DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 83.BRAZIL DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
  • TABLE 84.BRAZIL DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019-2027 ($MILLION)
  • TABLE 85.TURKEY DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 86.TURKEY DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
  • TABLE 87.TURKEY DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019-2027 ($MILLION)
  • TABLE 88.SAUDI ARABIA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 89.SAUDI ARABIA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
  • TABLE 90.SAUDI ARABIA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019-2027 ($MILLION)
  • TABLE 91.SOUTH AFRICA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 92.SOUTH AFRICA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
  • TABLE 93.SOUTH AFRICA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019-2027 ($MILLION)
  • TABLE 94.REST OF LAMEA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 95.REST OF LAMEA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
  • TABLE 96.REST OF LAMEA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019-2027 ($MILLION)
  • TABLE 97.LAMEA DIGITAL THERAPEUTICS MARKET, BY APPLICATION, 2019-2027 ($MILLION)
  • TABLE 98.LAMEA DIGITAL THERAPEUTICS MARKET, BY PRODUCT TYPE, 2019-2027 ($MILLION)
  • TABLE 99.LAMEA DIGITAL THERAPEUTICS MARKET, BY SALES CHANNEL, 2019-2027 ($MILLION)
  • TABLE 100.2MORROW: COMPANY SNAPSHOT
  • TABLE 101.WELLDOC: PRODUCT PORTFOLIO
  • TABLE 102.AKILI: COMPANY SNAPSHOT
  • TABLE 103.AKILI: PRODUCT PORTFOLIO
  • TABLE 104.CLICK THERAPEUTICS: COMPANY SNAPSHOT
  • TABLE 105.CLICK THERAPEUTICS: PRODUCT PORTFOLIO
  • TABLE 106.FITBIT: COMPANY SNAPSHOT
  • TABLE 107.FITBIT: PRODUCT PORTFOLIO
  • TABLE 108.HAPPIFY: COMPANY SNAPSHOT
  • TABLE 109.HAPPIFY: PRODUCT PORTFOLIO
  • TABLE 110.KAIA: COMPANY SNAPSHOT
  • TABLE 111.KAIA: PRODUCT PORTFOLIO
  • TABLE 112.LIVONGO: COMPANY SNAPSHOT
  • TABLE 113.LIVONGO: PRODUCT PORTFOLIO
  • TABLE 114.MEDTRONIC: COMPANY SNAPSHOT
  • TABLE 115.MEDTRONIC: OPERATING SEGMENTS
  • TABLE 116.MEDTRONIC: PRODUCT PORTFOLIO
  • TABLE 117.OMADA: COMPANY SNAPSHOT
  • TABLE 118.OMADA: PRODUCT PORTFOLIO
  • TABLE 119.PEAR: COMPANY SNAPSHOT
  • TABLE 120.PEAR: PRODUCT PORTFOLIO
  • TABLE 121.PROTEUS: COMPANY SNAPSHOT
  • TABLE 122.PROTEUS: PRODUCT PORTFOLIO
  • TABLE 123.RESMED: COMPANY SNAPSHOT
  • TABLE 124.RESMED: OPERATING SEGMENTS
  • TABLE 125.RESMED: PRODUCT PORTFOLIO
  • TABLE 126.VOLUNTIS: COMPANY SNAPSHOT
  • TABLE 127.VOLUNTIS: OPERATING SEGMENTS
  • TABLE 128.VOLUNTIS: PRODUCT PORTFOLIO
  • TABLE 129.WELLDOC: COMPANY SNAPSHOT
  • TABLE 130.WELLDOC: PRODUCT PORTFOLIO

LIST OF FIGURES

  • FIGURE 01.DIGITAL THERAPEUTICS MARKET SEGMENTATION
  • FIGURE 02.TOP INVESTMENT POCKET IN DIGITAL THERAPEUTICS MARKET, 2019
  • FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2016-2020*
  • FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2016-2020* (%)
  • FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2016-2020*
  • FIGURE 06.TOP PLAYER POSITIONING, 2019
  • FIGURE 07.MODERATE BARGAINING POWER OF SUPPLIERS
  • FIGURE 08.HIGH BARGAINING POWER OF BUYERS
  • FIGURE 09.LOW THREAT OF SUBSTITUTION
  • FIGURE 10.MODERATE THREAT OF NEW ENTRANT
  • FIGURE 11.MODERATE COMPETITIVE RIVALRY
  • FIGURE 12.GLOBAL DIGITAL THERAPEUTICS MARKET: RESTRAINTS, DRIVERS, AND OPPORTUNITY
  • FIGURE 13.DIGITAL THERAPEUTICS MARKET, BY APPLICATION
  • FIGURE 14.COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR DIABETES, BY COUNTRY, 2019 & 2027, ($MILLION)
  • FIGURE 15.COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR OBESITY, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 16.COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 17.COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR CENTRAL NERVOUS SYSTEM DISEASES, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 18.COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR GASTROINTESTINAL DISORDER, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 19.COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR RESPIRATORY DISEASES, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 20.COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR SMOKING CESSATION, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 21.COMPARATIVE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR OTHERS, BY COUNTRY, 2019 & 2027 ($MILLION)
  • FIGURE 22.DIGITAL THERAPEUTICS MARKET, BY PRODUCT
  • FIGURE 23.COMPARATIVE SHARE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR SOFTWARE, BY COUNTRY, 2017 & 2024 (%)
  • FIGURE 24.COMPARATIVE SHARE ANALYSIS OF DIGITAL THERAPEUTICS MARKET FOR DEVICES, BY COUNTRY, 2019 & 2027 (%)
  • FIGURE 25.DIGITAL THERAPEUTICS MARKET BY SALES CHANNEL
  • FIGURE 26.DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY EMPLOYER, 2019-2027 ($MILLION)
  • FIGURE 27.DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY HEALTHCARE PROVIDERS, 2019-2027 ($MILLION)
  • FIGURE 28.DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-BUSINESS SALES CHANNEL, BY OTHERS, 2019-2027 ($MILLION)
  • FIGURE 29.COMPARATIVE ANALYSIS OF BUSINESS-TO-BUSINESS MARKET, BY COUNTRY 2019 & 2027 ($MILLION)
  • FIGURE 30.DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY PATIENTS, 2019-2027 ($MILLION)
  • FIGURE 31.DIGITAL THERAPEUTICS MARKET FOR BUSINESS-TO-CONSUMERS SALES CHANNEL, BY CAREGIVERS, 2019-2027 ($MILLION)
  • FIGURE 32.COMPARATIVE ANALYSIS OF BUSINESS-TO-CONSUMERS, BY COUNTRY 2019 & 2027 ($MILLION)
  • FIGURE 33.FITBIT: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 34.FITBIT: NET SALES, BY REGION, 2019 (%)
  • FIGURE 35.MEDTRONIC: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 36.MEDTRONIC: REVENUE SHARE, BY SEGMENT, 2020 (%)
  • FIGURE 37.MEDTRONIC: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 38.RESMED: NET SALES, 2018-2020 ($MILLION)
  • FIGURE 39.RESMED: REVENUE SHARE, BY REGION, 2020 (%)
  • FIGURE 40.VOLUNTIS: NET SALES, 2017-2019 ($MILLION)
  • FIGURE 41.VOLUNTIS: REVENUE SHARE, BY SEGMENT, 2019 (%)
  • FIGURE 42.VOLUNTIS: REVENUE SHARE, BY REGION, 2019 (%)